ArticleFrontiers in pharmacology2025

Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study.

Ji-Xin Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.